Record added: Oct. 24, 2017, 9:41 a.m.
Record updated: Oct. 5, 2020, 4:31 p.m. by The FAIRsharing Team.

Edits to 'https://fairsharing.org/FAIRsharing.a557he' by 'The FAIRsharing Team' at 16:31, 05 Oct 2020 (not approved):

	'user_defined_tags' has been modified:
		Before:
			Approved drug
		After:
		Added:
		Removed:
			Approved drug

	'miriam_id' has been modified:
		Before: 
		After: None

	'onto_domains' has been modified:
		Before:
			Adverse Reaction
			cardiovascular disease
		After:
			Adverse Reaction
			Approved drug
			cardiovascular disease
		Added:
			Approved drug
		Removed:

            

Edits to 'https://fairsharing.org/FAIRsharing.a557he' by 'The FAIRsharing Team' at 19:43, 19 Feb 2018 (approved):

	'description' has been modified:
		Before: OCVDAE is a biomedical ontology of cardiovascular disease drug-associated adverse events
		After: With increased usage of cardiovascular drugs (CVDs) for treating cardiovascular diseases, it is important to analyze CVD-associated adverse events (AEs). The Ontology of Cardiovascular Drug Adverse Events (OCVDAE) is an ontology of adverse events associated with cardiovascular disease drugs. It extends the Ontology of Adverse Events (OAE) and NDF-RT. OCVDAE includes 194 CVDs, CVD ingredients, mechanisms of actions (MoAs), and CVD-associated 736 AEs.